Brain fog breakthrough? steroid trial for long COVID memory loss
NCT ID NCT05986422
First seen May 13, 2026 · Last updated May 16, 2026 · Updated 2 times
Summary
This study tested whether the steroid methylprednisolone could improve memory and thinking in people with post-COVID syndrome (brain fog). About 96 adults with long COVID and memory complaints were randomly assigned to take the drug or a placebo for six weeks. The trial was stopped early, so results are limited, but the goal was to see if a short course of this anti-inflammatory drug could ease cognitive symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST-COVID-19 SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, 10117, Germany
Conditions
Explore the condition pages connected to this study.